Shares of Monsanto (NYSE: MON) traded up last week after the agribusiness giant received a $62 billion takeover bid from Germany’s Bayer. That initial offer was quickly rejected, with Monsanto CEO Hugh Grant quoted as saying that it “significantly undervalues” the company. But that’s probably only the beginning of what promises to be a long dance between the two companies.